SEC Form D · filed March 5, 2018
Finch Therapeutics Group, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (27)
James Burgess · Somerville, MADirectorBenjamin Enerson · Somerville, MAExecZain Kassam · Somerville, MAExecChris Lange · Somerville, MADirectorAndrew Noh · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorR. J. Price · Somerville, MADirectorMark Smith · Somerville, MAExec · DirectorJeffery A. Smisek · Somervlle, MADirectorKerry Song · San Clemente, CAExecDavid T. Sinclair · Boston, MADirectorAlexander T. Edwards · Boston, MAExecAllison Harr · Seattle, WADirectorCarter G. Mcnabb · Louisville, CODirectorMichael Galgon · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorTao R. Wang · Newtown Square, PADirectorLair G. Kennedy · Louisville, CODirectorTimothy H. Baynes · Strafford, MODirectorJackie N. Charlesworth · Hong Kong, Hong KongDirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMilton Berlinski · New York, NYDirectorPeter Aberg · New York, NYDirectorTodd Haskins · New York, NYDirectorMarc N. Puglia · PROVIDENCE, RIDirectorPatrick Dunn · PROVIDENCE, RIExecHarry W. Lengsfield · NEW YORK, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗